ALPHAVOG M 0.2MG TABLET 10S

Product Introduction:

AlphaVog M 0.2mg Tablet is a medication used in the management of type 2 diabetes mellitus. It is a combination tablet containing two active ingredients: Metformin (500mg) and Voglibose (0.2mg). Metformin belongs to the biguanide class of antidiabetic drugs, while Voglibose is an alpha-glucosidase inhibitor. This combination is designed to help control blood sugar levels in patients with type 2 diabetes by targeting different aspects of glucose metabolism.

Alphavog M 0.2mg Tablet should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.

Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.

This medicine may cause side effects like nausea, taste change, loss of appetite, flatulence, stomach pain, diarrhea, and skin rash. However, these are temporary and usually subside on their own. If these do not resolve or worry you, please consult your doctor. Your doctor might suggest ways of dealing with your side effects or treating them if they are bothersome.

You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

Benefits:

1. Blood Glucose Control: AlphaVog M 0.2mg Tablet helps in controlling postprandial (after-meal) blood glucose levels in patients with type 2 diabetes mellitus.
2. Reduced Glycemic Variability: Voglibose slows down carbohydrate digestion, reducing spikes in blood sugar levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, leading to overall better control of blood glucose levels.
3. Weight Management: Metformin is associated with weight loss or weight stabilization in some individuals, which can be beneficial for overweight or obese patients with diabetes.
4. Cardiovascular Benefits: Some studies suggest that Metformin may have cardiovascular benefits beyond glycemic control, potentially reducing the risk of cardiovascular events in diabetic patients.

Side Effects:

Common side effects of AlphaVog M 0.2mg Tablet may include:

1. Gastrointestinal Disturbances: These may include nausea, vomiting, diarrhea, or abdominal discomfort, particularly during the initial stages of treatment.
2. Flatulence: Increased gas production and flatulence are common side effects due to undigested carbohydrates reaching the colon, which is a result of Voglibose’s mechanism of action.
3. Lactic Acidosis: While rare, Metformin can cause a serious condition called lactic acidosis, characterized by symptoms such as muscle pain, weakness, difficulty breathing, and abdominal discomfort.
4. Hypoglycemia: Hypoglycemia (low blood sugar) is rare with this combination but may occur, especially if the medication is taken with other antidiabetic medications.

Usage Guidelines:

1. Dosage: The usual recommended dosage of AlphaVog M 0.2mg Tablet is one tablet taken orally three times a day, immediately before each main meal.
2. Administration: Swallow the tablet whole with a glass of water. It is typically taken before meals to inhibit the digestion of carbohydrates.
3. Dietary Considerations: Patients should follow a balanced diet and meal plan as recommended by their healthcare provider while taking AlphaVog M 0.2mg Tablet.
4. Monitoring: Regular monitoring of blood glucose levels, as well as kidney and liver function tests, may be required during treatment with this medication.

Drug Interactions:

1. Other Antidiabetic Medications: Concurrent use of AlphaVog M 0.2mg Tablet with other antidiabetic medications may increase the risk of hypoglycemia.
2. Alcohol: Alcohol consumption may potentiate the hypoglycemic effects of Metformin and increase the risk of lactic acidosis.
3. Certain Medications: Some medications, such as certain antibiotics, may interact with Metformin and increase the risk of lactic acidosis.

Before starting AlphaVog M 0.2mg Tablet, patients should inform their healthcare provider about all medications, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions. Adhering to the prescribed dosage and dietary recommendations is crucial for optimal efficacy and safety. Any concerns or adverse effects should be promptly reported to the healthcare provider.

SAFETY ADVICE

Alcohol

UNSAFE

It is unsafe to consume alcohol with Alphavog M 0.2mg Tablet.

Pregnancy

CONSULT YOUR DOCTOR

Alphavog M 0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Alphavog M 0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

SAFE

Alphavog M 0.2mg Tablet does not usually affect your ability to drive.
However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.

Kidney

CAUTION

Alphavog M 0.2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Alphavog M 0.2mg Tablet may be needed. Please consult your doctor.
Use of Alphavog M 0.2mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Liver

CONSULT YOUR DOCTOR

There is limited information available on the use of Alphavog M 0.2mg Tablet in patients with liver disease. Please consult your doctor.